
Sanofi to outsource antiinfectives R&D to Evotec
Under the deal, Sanofi wants to licence its early stage antimicrobial development programmes (more than 10), and transfer its antifectives unit in...

GBS 2018: Bioeconomy leaders foster shift to sustainable industry production
For two days, 800+ policy leaders, NGO and industry representatives from over 70 nations met to discuss the challenges and opportunities of the shift...

Alexion in €639m bid for Wilson Therapeutics AB
Alexion’s offer represents a 70% premium compared to the closing share price on the last trading day prior to announcement of its offer and a 373%...

Medimmune finds target against systemic sclerosis
The team headed by Devon Taylor identified a set of CD4-positive T-cells, which express the protein inducible costimulator (ICOS) in human skin,...

Eylea met Phase III endpoint in diabetic retinopathy
According to Regeneron, the fusion protein of extracellular VEGF-receptor 1 and 2-fragments with the FC portion of IgG1, improved the Diabetic...

European biotech stocks: 2017 with strong results
Following the more cautious year 2016, the European biotech sector witnessed a significant volume increase in IPOs and follow-on financings in 2017....

Bioeconomy: Bringing in the public
In three years of work, the BioSTEP experts from five European countries organised discussions, workshops, conferences or living lab...